Hybridoma cell lines and monoclonal antibodies to theophylline

Details Hybridoma cell lines and monoclonal antibodies to theophylline Hybridoma cell lines and monoclonal antibodies to theophylline

1984-01-03

1985-06-04

Shapiro, Lionel M.

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

435240, 435211, 435 68, 435948, 436548, 260112R, 260112B, 424 85, C12P 2100, C12N 500, G01N 3354, A23J 100

Patent

active

045215103

ABSTRACT:
Monoclonal antibodies to theophylline having 5% or less cross-reactivity with caffeine and the continuous hybrid monoclonal cell lines for their production are provided. These antibodies are useful in a particle-enhanced turbidimetric inhibition immunoassay for theophylline.

REFERENCES:
patent: 4156801 (1979-05-01), Singh et al.
patent: 4230805 (1980-10-01), Singh et al.
patent: 4260089 (1981-04-01), Singh et al.
patent: 4401765 (1983-08-01), Craig et al.

Affiliated with

Also associated with

Rating

Hybridoma cell lines and monoclonal antibodies to theophylline does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hybridoma cell lines and monoclonal antibodies to theophylline, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hybridoma cell lines and monoclonal antibodies to theophylline will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-829171